These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3079080)

  • 21. Donor-specific transfusion with and without cyclosporine A--a controlled clinical trial.
    Sells RA; Hillis A; Bone MJ; Evans P; Evans CM; Scott MM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):270-3. PubMed ID: 3291255
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
    Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
    Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors on graft survival of living donor kidney transplantation.
    Park YH; Min SK; Lee JN; Lee HH; Jung WK; Lee JS; Lee JH; Lee YD
    Transplant Proc; 2004 Sep; 36(7):2023-5. PubMed ID: 15518732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation from HLA-haploidentical living donors. Efficacy of cyclosporine in a multicenter study.
    Albrechtsen D; Flatmark A; Lundgren G; Brynger H; Frödin L; Groth C; Gäbel H; Thorsby E
    Transplant Proc; 1987 Oct; 19(5):3579-81. PubMed ID: 2960040
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
    Martin DC; Hewitt CW; Black KS; Reyes M; Go C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
    [No Abstract]   [Full Text] [Related]  

  • 28. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 29. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine.
    Albrechtsen D; Flatmark A; Leivestad T; Brynger H; Frødin L; Groth CG; Lundgren G; Persson N
    Transplant Proc; 1990 Feb; 22(1):214-5. PubMed ID: 2408207
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
    Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
    [No Abstract]   [Full Text] [Related]  

  • 32. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 33. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Rubin AL; Stenzel KH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1023. PubMed ID: 1989145
    [No Abstract]   [Full Text] [Related]  

  • 34. Donor-specific transfusion.
    Iwaki Y; Terasaki PI
    Clin Transpl; 1986; ():267-75. PubMed ID: 3154415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal transplantation from living donors mismatched for two HLA haplotypes.
    Sødal G; Albrechtsen D; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Talseth T; Thorsby E; Flatmark A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022
    [No Abstract]   [Full Text] [Related]  

  • 36. A single center experience with cyclosporine in renal transplantation: Ohio State University 1983 to 1987.
    Ferguson RM; Henry ML; Sommer BG; Sachs L; Orosz CG
    Clin Transpl; 1987; ():195-207. PubMed ID: 3154402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living donor kidney transplants.
    Cicciarelli J
    Clin Transpl; 1988; ():293-9. PubMed ID: 3154482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living related donor kidney transplantation at a Turkish center.
    Hamaloğlu E; Tokyay R; Arslan G; Bilgin N; Büyükpamukçu N; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1848-9. PubMed ID: 1412878
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of donor and recipient age on graft survival rate after renal transplantation with a protocol of low CyA doses.
    Morales JM; Campo C; Hernandez E; Andres A; Praga M; Montoyo C; Ortuño T; Mosquera JR; Rodicio JL
    Transplant Proc; 1991 Oct; 23(5):2622-3. PubMed ID: 1926508
    [No Abstract]   [Full Text] [Related]  

  • 40. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.